CareDx Posts $19.3 Million Q3 Net Income, Revenue of $139.4 Million

CareDx Inc. (CDNA) on Thursday reported third-quarter net income of $19.3 million, or 35 cents per share, the Brisbane, California-based molecular diagnostics company said. Adjusted earnings, excluding stock option expense and non-recurring costs, came to 70 cents per share. Revenue for the period totaled $139.4 million. The company guided full-year revenue to a range of $520 million to $530 million.